The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. [electronic resource]
Producer: 20090406Description: 425-32 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Female
- Fluorodeoxyglucose F18
- Humans
- Lymphoma, Non-Hodgkin -- diagnosis
- Male
- Metabolism
- Middle Aged
- Neoplasm, Residual -- diagnosis
- Positron-Emission Tomography
- Prognosis
- Remission Induction
- Survival Analysis
- T-Lymphocytes
- Tomography, X-Ray Computed
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.